Tomas Gabriel Bas

Prof. Dr. Tomas Gabriel Bas

Escuela de Ciencias Empresariales, Universidad Católica del Norte, Coquimbo, Chile
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TBTomas Gabriel Bas
Tomas Gabriel Bas
This article presents a groundbreaking perspective on carotenoids, focusing on their innovative applications and transformative potential in human health and medicine. Research jointly delves deeper into the bioactivity and bioavailability of carotenoids, revealing therapeutic uses and technological advances that have the potential to revolutionize medical treatments. We explore pioneering therapeutic applications in which carotenoids are used to treat chronic diseases such as cancer, cardiovascular disease, and age-related macular degeneration, offering novel protective mechanisms and innovative therapeutic benefits. Our study also shows cutting-edge technological innovations in carotenoid extraction and bioavailability, including the development of supramolecular carriers and advanced nanotechnology, which dramatically improve the absorption and efficacy of these compounds. These technological advances not only ensure consistent quality but also tailor carotenoid therapies to each patient’s health needs, paving the way for personalized medicine. By integrating the latest scientific discoveries and innovative techniques, this research provides a prospective perspective on the clinical applications of carotenoids, establishing a new benchmark for future studies in this field. Our findings underscore the importance of optimizing carotenoid extraction, administration, bioactivity, and bioavailability methods to develop more effective, targeted, and personalized treatments, thus offering visionary insight into their potential in modern medical practices.

Verified
Journal Article
Open access
PDF file
TBTomas Gabriel Bas
Tomas Gabriel Bas
Plant polyphenols, particularly flavonoids, are prominent bioactives in preventive/complementary therapeutic strategies. This article analyzes how some polyphenols can mitigate oxidative stress and inflammation. These processes are involved in cardiovascular disease, cancer, neurodegeneration, and metabolic disorders. Polyphenols are explored through the integration of direct antioxidant chemistry (radical scavenging via hydrogen atom transfer/single-electron transfer/metal chelation), redox signaling (Keap1–Nrf2/ARE and inflammatory pathways), endogenous antioxidant enzyme systems, and mitochondrial quality control. Unlike previous descriptive reviews, a novel aspect of this manuscript is its evidence-based synthesis, fully supported by structured summary tables that explicitly detail limitations, contradictions, and context dependencies in in vitro, in vivo, and human studies, and identify clinically interpretable endpoints for their application. We describe relevant flavonoids and dietary sources, along with functional outcomes in cardiometabolic–cognitive/neuroprotective–immunometabolic contexts. We integrate representative clinical interventions and nutraceutical applications, highlighting where reported benefits are supported and where the evidence is preliminary. Bioavailability, microbiota-driven biotransformation, and dose realism are considered the primary determinants of in vivo relevance, rather than secondary or descriptive considerations. Future research should prioritize standardized exposure and metabolite profile, dose-appropriate interventions, harmonized clinical endpoints, and stratification strategies that account for microbiome-driven interindividual variability to improve reproducibility and inform nutraceutical and therapeutic use.

17 June 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
TBTomas Gabriel Bas
Tomas Gabriel Bas
The formulation of biosimilar products critically determines their stability, safety, immunogenicity, and market accessibility. This article presents a novel integrative framework for biosimilar formulation that balances scientific, regulatory, and intellectual property dimensions, offering a holistic perspective rarely unified in the literature. It highlights the growing trend toward buffer-free, high-concentration systems that leverage protein self-buffering to improve patient comfort and formulation stability. The article also addresses regulatory flexibility from the FDA and EMA, which allows scientifically justified deviations from reference formulations to ensure pharmaceutical equivalence and minimize immunogenicity. A novelty of this article is its comprehensive analysis of how digital innovations, such as Quality-by-Design, Process-Analytical-Technology, and AI-based in silico simulations, are transforming formulation design and bioprocess optimization to reduce immunogenic risks and enhance bioequivalence. Two important key takeaways emerge: (1) strategic innovation in formulation, especially using buffer-free and high concentration systems, improve product stability and patient tolerability while complying with regulatory standards; and (2) intellectual property challenges, including patent thickets, strongly influence formulation decisions, making early legal-strategic alignment essential for market entry. The article confirms that practical recommendations for the selection of recombinant therapeutic protein formulations can effectively guide developers and regulators toward safer, more efficient, and commercially viable biosimilar products.

1 October 2003 in European Planning Studies
Verified
Journal Article
Closed access
JNJorge Niosi
Jorge Niosi
TBTomas Gabriel Bas
Tomas Gabriel Bas
Canada hosts two major diversified biotechnology regional systems of innovation in its two largest cities. Similar in many respects, they display some particular characteristics. We review here the main theories on regional innovation systems and innovative clusters and proceed to analyse these two regional systems before concluding on the usefulness of several theories to study biotechnology regional innovation systems.|spagf|ro|epagf|

8 December 2022 in Fishes
Verified
Journal Article
Open access
PDF file
JBJosé Antonio Bakit
José Antonio Bakit
Gonzalo ÁlvarezGonzalo Álvarez
Gonzalo Álvarez
Patricio  DíazPatricio Díaz
Patricio Díaz
EUEduardo Uribe
Eduardo Uribe
RSRodrigo Sfeir
Rodrigo Sfeir
Jose Castillo-VenencianoJose Castillo-Venenciano
Jose Castillo-Venenciano
The boom-and-bust trajectory of the Argopecten purpuratus industry in Chile shows the progression from resource extraction (fishing) to production (aquaculture). This paper analyses the effects of environmental, economic, and scientific–technological factors. The influence of each factor on scallop production in Chile was reviewed for the period between the 1980s and 2020. The evaluation of the effects allows the visualisation of the industry’s productive evolution and reveals the current challenges. The occurrence of abrupt environmental disturbances, commercialisation under imperfect market configurations, and public and private efforts in scientific and technological advances have acted favourably on scallop production. However, an industry mainly focused on prices and high production volumes did not devote much effort to develop low-cost climate-resilient technologies. Today, economic challenges must be addressed by helping to reduce production costs and add economic value to products and by-products. Our results show that the industry must focus on low-cost technologies, the use of renewable energy, and the circularity of its processes. The environment ensures the capture of natural seeds and their adaptation to climate change. These challenges must not lose sight of the emerging effects of the COVID-19 pandemic.

12 January 2025 in Agriculture
Verified
Journal Article
Open access
PDF file
TBTomas Gabriel Bas
Tomas Gabriel Bas
This article analyses the impacts of the Russia–Ukraine conflict and the COVID-19 pandemic on the supply chain and logistics related to the management of agro-food production based on a comprehensive review of the scientific literature. The challenges and lessons posed by market dependence in a scenario of globalization through monopolies and oligopolies in the production and export of agro-food are assessed, highlighting the vulnerability and uncertainty faced when an international conflict occurs. The review examines the format of globalization versus glocalization, analyzing their respective advantages and disadvantages in supply chains and management in the context of two major crises such as the COVID-19 pandemic and the armed conflict between Ukraine and Russia. Likewise, the resilience of agro-food and agro-industrial systems that were negatively affected by food insecurity and food price inflation in parts of Europe, Africa, and other regions of the planet is analyzed. By identifying opportunities arising from these challenges, the research offers insights into fostering a more robust agro-food supply chain that is more adaptable to global crises based on the geographic location and regional development of agribusinesses capable of responding to demand in the event of a global crisis such as a pandemic or armed conflict.